These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 11071023)

  • 1. Increased risk of side-effects in psychiatric patients treated with clozapine and carbamazepine: a reanalysis.
    Langbehn DR; Alexander B
    Pharmacopsychiatry; 2000 Sep; 33(5):196. PubMed ID: 11071023
    [No Abstract]   [Full Text] [Related]  

  • 2. Increased risk of hematological side-effects in psychiatric patients treated with clozapine and carbamazepine?
    Junghan U; Albers M; Woggon B
    Pharmacopsychiatry; 1993 Nov; 26(6):262. PubMed ID: 8127933
    [No Abstract]   [Full Text] [Related]  

  • 3. Increased use of antibiotics in patients treated with clozapine.
    Nielsen J; Foldager L; Meyer JM
    Eur Neuropsychopharmacol; 2009 Jul; 19(7):483-6. PubMed ID: 19356909
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Late-onset agranulocytosis in a patient treated with clozapine and lamotrigine.
    Tourian L; Margolese HC
    J Clin Psychopharmacol; 2011 Oct; 31(5):665-7. PubMed ID: 21881454
    [No Abstract]   [Full Text] [Related]  

  • 5. [Chemotherapy during clozapine treatment. Increased risk of agranulocytosis?].
    van Gool AR; van der Velden MT; Oosten AW; van Meerten E; Verhoeven WM; Loonen AJ
    Tijdschr Psychiatr; 2008; 50(10):673-8. PubMed ID: 18951346
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Hematologic effects of clozapine: a review of the international experience].
    Lamarque V
    Encephale; 1996 Dec; 22 Spec No 6():35-6. PubMed ID: 9102319
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serious erythromycin interactions caused by inhibition of drug metabolism in the liver.
    Wynn RL
    Gen Dent; 1996; 44(6):486-8, 490. PubMed ID: 9515389
    [No Abstract]   [Full Text] [Related]  

  • 8. Clozapine, agranulocytosis, and benign ethnic neutropenia.
    Rajagopal S
    Postgrad Med J; 2005 Sep; 81(959):545-6. PubMed ID: 16143678
    [No Abstract]   [Full Text] [Related]  

  • 9. [Risk minimization evolution of agranulocytosis caused by the administration of pharmaceutical products containing Clozapine in Argentina].
    Bergman M; Bignone I; Bisio A; Bologna V; Sabatini A
    Vertex; 2011; 22(96):94-7. PubMed ID: 21977603
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Testing the hypothesis that selenium deficiency is a risk factor for clozapine-induced agranulocytosis in rats.
    Ip J; Uetrecht JP
    Chem Res Toxicol; 2008 Apr; 21(4):874-8. PubMed ID: 18380444
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Patient knowledge regarding Clozapine-induced agranulocytosis].
    Haberfellner EM; Rittmannsberger H
    Psychiatr Prax; 2006 May; 33(4):194-6. PubMed ID: 16680627
    [No Abstract]   [Full Text] [Related]  

  • 12. [Clozapine-induced agranulocytosis: genetic risk factors and an immunologic explanatory model].
    Güzelcan Y; Scholte WF
    Tijdschr Psychiatr; 2006; 48(4):295-302. PubMed ID: 16955993
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Testing the hypothesis that vitamin C deficiency is a risk factor for clozapine-induced agranulocytosis using guinea pigs and ODS rats.
    Ip J; Wilson JX; Uetrecht JP
    Chem Res Toxicol; 2008 Apr; 21(4):869-73. PubMed ID: 18380445
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phenytoin intoxication in a clozapine-related prolonged seizure.
    Gandelman-Marton R; Theitler J; Klein C; Rabey JM
    J Emerg Med; 2008 Nov; 35(4):407-9. PubMed ID: 17961958
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term combination treatment with clozapine and filgrastim in patients with clozapine-induced agranulocytosis.
    Hägg S; Rosenius S; Spigset O
    Int Clin Psychopharmacol; 2003 May; 18(3):173-4. PubMed ID: 12702898
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clozapine alone versus clozapine and risperidone for refractory schizophrenia.
    Gerson SL
    N Engl J Med; 2006 Apr; 354(17):1846-8; author reply 1846-8. PubMed ID: 16642587
    [No Abstract]   [Full Text] [Related]  

  • 17. Risk of clozapine-associated agranulocytosis and mandatory white blood cell monitoring.
    Schulte P
    Ann Pharmacother; 2006 Apr; 40(4):683-8. PubMed ID: 16595571
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Three potentially fatal adverse effects of psychotropic medications.
    Wren P; Frizzell LA; Keltner NL; Wright AV
    Perspect Psychiatr Care; 2003; 39(2):75-81. PubMed ID: 12894601
    [No Abstract]   [Full Text] [Related]  

  • 19. Combining atomoxetine with carbamazepine or neuroleptics reduces adverse side effects.
    Niederhofer H
    J Paediatr Child Health; 2010 Jan; 46(1-2):66. PubMed ID: 20412195
    [No Abstract]   [Full Text] [Related]  

  • 20. Long-term patient monitoring for clozapine-induced agranulocytosis and neutropenia in Korea: when is it safe to discontinue CPMS?
    Kang BJ; Cho MJ; Oh JT; Lee Y; Chae BJ; Ko J
    Hum Psychopharmacol; 2006 Aug; 21(6):387-91. PubMed ID: 16933201
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.